Uncoupling protein 2 (UCP2), whose physiological role is to decrease mitochondrial membrane potential and reactive oxygen species (ROS) production, is often overexpressed in human cancers. UCP2 upregulation has recently been proposed as a novel survival mechanism for cancer cells. However, until now, how exactly UCP2 promotes tumorigenesis remains inconclusive. Based on a widely used skin cell transformation model, our data demonstrated that UCP2 differentially regulated ROS. UCP2 upregulation decreased superoxide whereas it increased hydrogen peroxide production with concomitant increase in the expression and activity of manganese superoxide dismutase (MnSOD), the primary mitochondrial antioxidant enzyme. Furthermore, hydrogen peroxide was responsible for induction of lipid peroxidation, and PLCγ-1 activation in UCP2 overexpressed cells. Additionally, PLCγ-1 activation enhanced skin cell transformation, and pharmacological, and siRNA mediated inhibition of PLCγ-1, markedly reduced colony formation, and 3D cell growth. Moreover, hydrogen peroxide scavenger, catalase, suppressed lipid peroxidation, and dampened PLCγ-1 activity.
(SOD, catalase, GPx, etc) which are located in both mitochondria, and cytosol. Balancing ROS generation, and ROS elimination to maintain ROS homeostasis is a critical regulator for cell functioning, and cell survival. Not surprisingly, this balance is often dysregulated in cancer cells, leading to abnormal tumor growth. [8] [9] [10] ROS and oxidative stress are intricate processes in cancer. Due to persistent oxidative stress, cancer cells become well-adapted, and develop enhanced resistance, and simply adding ROS-generating agents may not always be sufficient to kill tumor cells. 11 To cope with enhanced oxidative stress, and such an insult to the cell, cancer cells also activate their ROS-scavenging system. 12 This could lead to tumor resistance, and thus, a failure to respond to conventional chemotherapeutic drugs.
Recently, mitochondrial uncoupling protein 2 (UCP2), one of the mitochondrial anion transporter protein, is receiving more attention as a crucial regulator of mitochondrial ROS. UCP2, unlike other members in this family, is ubiquitously expressed, and plays a critical role as an antioxidant defense mechanism. 13, 14 Recent studies from others' and our lab have shown that UCP2 is upregulated in several human cancers. 15 In cancer cells, UCP2 are thought to be activated by superoxide, and in turn, elevated levels of UCP2 decreases superoxide production via uncoupling, providing growth advantage to tumor cells. [16] [17] [18] In addition, UCP2 may also contribute to cancer progression via regulating cancer metabolism. 19 Besides being an anion transporter, UCP2 has been shown to be able to transport TCA cycle C4 metabolites. 20 However, there was no direct evidence supporting the tumor promoting role of UCP2, using genetically modified mice. Using UCP2 knockout, and wildtype mice, our lab showed that knockout of UCP2 reduced skin papilloma, and carcinoma formation in mice, linking UCP2, and tumor promotion. 21 However, till date, the tumor promoting role of UCP2 remains questionable. In the present study, we examined the role of UCP2 in redox regulation, and lipid signaling using a skin cell transformation model, and studied how UCP2 overexpression tuned redox balance, and how it affected downstream lipid signaling. 
| MATERIALS AND METHODS

| Cell culture and treatments
| Cell transfection and gene knockdown
Target-specific siRNAs and siRNA transfection reagent (sc-36265, Santa Cruz Biotechnology) were used to inhibit PLCγ-1 expression.
Healthy and subconfluent UCP2 overexpressed, and control pCMV cells were transfected for 48 h before further analysis. A non-targeting siRNA (Santa Cruz Biotechnology) was used to monitor the transfection efficiency. The expression of target genes was further examined
by Western blot analysis with specific antibodies.
| Anchorage independent assay
Anchorage independent growth assay or the soft agar assay was performed using PLCγ-1 siRNA and control siRNA cells. A total of 0.5%
Agar mix (40 mL melted 1.25% agar solution, 40 mL 2 × EMEM, 10 mL FBS, 10 mL PBS, 1 mL glutamine, 50 μL penicillin & streptomycin) was prepared, and kept in a 50°C water bath. Bottom agar was prepared by adding DMSO and/or TPA to the 0.5% agar mix. Top agar was prepared by diluting 1 fraction of 1 × 10 5 cells/mL single cell suspension with two fractions of 0.5% agar mix, and treatments. A total of 2.5 mL of bottom agar and 0.75 mL of top agar was laid into each well of the 6-well plates. Cells were incubated in a humidified 37°C, 5% CO 2 incubator for 2 weeks. Cells were then stained with 0.25 mg/mL neutral red overnight, and the number of colonies were counted, and plotted.
| Detection of oxidatively modified proteins (protein carbonyls)
The Oxyblot protein oxidation detection kit (EMD Millipore, Billerica, MA, S7150) was used to perform the assay. The reaction procedures were conducted according to the manufacturer's instructions. Ten percent SDS-PAGE gels were used for the separation of the mixture of the Whole Cell Lysate (n = 8 per group). was performed according to the manufacturer's protocol. Samples absorbance was measured using a spectrophotometer at 532 nm (n = 4 per group). 
| Lipid peroxidation measurement
| Cell proliferation assay
JB6 cells were seeded at a 3000 cells/well density into a 96-well plate.
The cells were subjected to overnight incubation in the IncuCyte Essens Bioscience Incubator (Birmingham, UK) under 5% CO 2 and at a temperature of 37°C. The cells were imaged every 4 h and the proliferation rates based on confluency were determined using the IncuCyte software.
| IP3 and DAG measurements
The measurements of IP3 and DAG were conducted using IP3 and 
| Statistical analysis
All experiments were repeated at least three times and each experiment group included at least three samples. Multiple group comparisons were analyzed by two-way analysis of variance (ANOVA).
Data were presented as mean ± standard error (SEM). Statistical software SAS 9.4 (SAS Institute Inc, Cary, NC) was used for all data analysis. P-value <0.05 was regarded as statistically significant.
3 | RESULTS
| UCP2 differentially regulated ROS production
It is well known that elevated levels of ROS are implicated in cancer, and uncoupling proteins are associated with mitochondrial ROS production.
Superoxide is shown to activate UCP2, and in turn, elevated UCP2 decreases superoxide via a negative feedback loop. 24, 25 In this study, we examined whether upregulation of UCP2 could decrease ROS produc- 
| UCP2 enhanced lipid and protein oxidation
Hydrogen peroxide is highly stable and a highly reactive agent. Under certain conditions hydrogen peroxide can react with a variety of cellular components including phospholipid cell membrane, DNA, and proteins. It can freely diffuse out of the mitochondria into the cytosol, causing lipid and protein oxidation. 27 Lipid peroxidation disrupts the . 1A) ; #P < 0.05 when compared with the control/TPA group normal structure and permeability of membrane and dramatically alters cell integrity. 28 Malondialdehyde (MDA) the end-product of lipid peroxidation, appears to be the most mutagenic and an effective marker for lipid peroxidation. 29 Hence, MDA production is a marker for lipid peroxidation in pCMV and UCP2 cells using the thiobarbituric acid (TBARS) assay. As shown in the Fig. 2A , higher levels of MDA were observed after TPA treatment, and UCP2 over-expression enhanced this increase, which is in agreement with elevated levels of hydrogen peroxides. Similar trends were also observed in the levels of oxidatively modified proteins (protein carbonyls), which show increased oxidation levels of multiple proteins (Fig. 2B ).
| UCP2 overexpressed enhanced PLCγ-1 signaling
To identify the potential signaling molecules regulated by UCP2 during skin cell transformation, a protein microarray has been performed previously. 21 Interestingly, as shown in Fig. 3A , PLCγ-1 (Phospholipase C gamma-1) was activated (as the measurement of Phospho-Tyr771) in the skin tumor samples of the wild-type mice, but not in the UCP2 knockout mice. PLCγ-1 is ubiquitously expressed, and plays an important role in regulating lipid signaling, cell proliferation, and differentiation. 30, 31 PLCγ-1 can be activated in response to oxidant injury, and cellular stress, and once activated, PLCγ-1 cleaves membrane phospholipid generating 2 s messengers, DAG and IP3, further stimulating intracellular calcium. 32 In the same protein array study, the calcium binding protein Calmodulin also was found to be increased in the tumor tissues of the wild-type, but not in the UCP2 knockout mice (Fig. 3B) . Although the physiological role of PLCγ-1 activation in tumor cell is unclear, studies have demonstrated that PLCγ-1 is often overexpressed in cancers. [33] [34] [35] [36] [37] To detect whether UCP2 overexpression enhanced PLCγ-1 expression, we examined the protein levels of PLCγ-1 and its phosphorylation status in UCP2 overexpressed and control pCMV vector cells. Since PLCγ-1 is a tyrosine kinase substrate, its activation requires the phosphorylation of tyrosine (Y) residue. Hence, we measured PLCγ-1 phosphorylation (Y783) using a phosphotyrosine-specific antibody. As shown in Fig. 3C , PLCγ-1 and pPLCγ-1 expression were indeed enhanced in UCP2 overexpressed cells, and in response to TPA treatment. To verify the activation of PLCγ-1, we measured its downstream targets. Both IP3
and DAG were elevated after TPA treatment, and UCP2 overexpressed enhanced these increases (Fig. 4A,B) . Therefore, intracellular calcium levels were increased in UCP2 overexpressed cells with or without TPA treatment as measured by either ELISA (Fig. 4C ) or fluorescent imaging (Fig. 4D,E [41] [42] [43] Addition of exogenous catalase to the growth culture media significantly inhibited the levels of hydrogen peroxide (Fig. 5A ), lipid peroxidation (Fig. 5B) , the increased expression of PLCγ-1 and pPLCγ-1 (Fig. 5C) , and its downstream targets IP3 and FIGURE 2 UCP2 enhanced lipid and protein oxidation. Detection of lipid peroxidation by the MDA assay (A, N = 4 per group) and protein oxidation by Oxiblot (B) in UCP2 overexpressed and control JB6 cells. These cells were treated with TPA (5 nM) or vehicle control (DMSO) for 24 h. For Oxiblot, the bands were detected on the same gel but the lanes were not adjacent. *P < 0.05 when compared with the its own control group. #P < 0.05 when compared with the control/TPA group DAG (Fig. 5D ,E). 3D spheroid growth was also inhibited by adding catalase (Fig. 5F ). These data suggest that UCP2-induced H 2 O 2 stimulates phosphorylation and activation of PLC-γ1 and is essential for downstream PLCγ-1 mediated signaling.
| Inhibition of PLCγ-1 suppressed cell proliferation, colony formation and 3D culture of UCP2 cells in vitro
To study the physiological relevance of PLCγ-1 activation in UCP2 overexpressed cells, and to determine the importance of PLCγ-1 in skin cell transformation, we inhibited PLCγ-1 expression by either the siRNA approach or by the PLCγ-1 inhibitor U73122. Using anchorage independent growth assay on control and siRNA transfected cells, we found that inhibition of PLCγ-1 (Fig. 6A ) significantly decreased the number of colonies formed in soft agar (Fig. 6B) .
Inhibition of PLCγ-1 significantly decreased cell proliferation (Fig. 6G) . Similarly, inhibition of PLCγ-1 with U72133 ( Fig. 6C) significantly decreased the 3D spheroid formation (Fig. 6F) , and suppressed the downstream targets IP3 and DAG levels (Fig. 6D,E) , suggesting that PLCγ-1 could be a dominant pathway in UCP2-induced tumor promotion. 
| DISCUSSION
Cancer cells often adapt their metabolism to suit their growth requirements, and metabolic reprogramming is one of the hallmarks of cancer. 53 More emphasis is being made on the avariciousness of cancer cells toward enhanced glycolysis (the Warburg Effect), enhanced glutamine oxidation, and fatty acid metabolism, thus, integrating multiple aspects of cancer metabolism, and bioenergetics. [54] [55] [56] [57] Since mitochondria play important roles in maintenance of cell growth, cell proliferation, and development, much attention has been dedicated toward mitochondrial dysfunction in cancer. 58 Deregulated cell proliferation, survival, and death are often associated with cancer.
Since tumor cells employ metabolic pathways to promote their growth and survival, metabolic reprogramming is firmly established as a hallmark of cancer cells.
49,59
Here we focus on the effects of UCP2 overexpression on mitochondrial redox regulation and metabolic regulatory networks.
ROS are produced in mitochondria as byproducts of oxidative phosphorylation. Superoxide, the primary and the most abundant ROS is generated at complexs I and III of the ETC. Superoxide is readily dismutated to hydrogen peroxide in the mitochondrial matrix by the free radicals leading to enhanced cell proliferation, differentiation and tumorigenesis. 71 Using JB6 cell lines that overexpress UCP2, we showed that UCP2 differentially regulates superoxide, and hydrogen peroxide during skin cell transformation. An interesting result of our study is that UCP2 overexpression decreases superoxide production but increases hydrogen peroxide with a concomitant increase in 
